| __timestamp | Amgen Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4699000000 | 2026300000 |
| Thursday, January 1, 2015 | 4846000000 | 2682700000 |
| Friday, January 1, 2016 | 5062000000 | 2810000000 |
| Sunday, January 1, 2017 | 4870000000 | 2582000000 |
| Monday, January 1, 2018 | 5332000000 | 2473000000 |
| Tuesday, January 1, 2019 | 5150000000 | 2554000000 |
| Wednesday, January 1, 2020 | 5730000000 | 2367000000 |
| Friday, January 1, 2021 | 5368000000 | 2624000000 |
| Saturday, January 1, 2022 | 5414000000 | 2625000000 |
| Sunday, January 1, 2023 | 6179000000 | 2917000000 |
| Monday, January 1, 2024 | 7096000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, operational efficiency is key. Over the past decade, Amgen Inc. and Bausch Health Companies Inc. have showcased distinct strategies in managing their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Amgen's SG&A expenses have grown by approximately 31%, peaking in 2023. This reflects a strategic investment in operational capabilities, possibly to support its expanding product portfolio. In contrast, Bausch Health's SG&A expenses have seen a more modest increase of around 44% over the same period, indicating a more conservative approach. Notably, Amgen's expenses consistently outpaced Bausch Health's, highlighting its aggressive market positioning. As the pharmaceutical landscape continues to shift, these trends offer a glimpse into the strategic priorities of two industry giants.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or Bausch Health Companies Inc.
Selling, General, and Administrative Costs: Amgen Inc. vs Sanofi
Operational Costs Compared: SG&A Analysis of Amgen Inc. and BioMarin Pharmaceutical Inc.
Who Optimizes SG&A Costs Better? Amgen Inc. or Galapagos NV
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Novavax, Inc.
Selling, General, and Administrative Costs: Halozyme Therapeutics, Inc. vs Bausch Health Companies Inc.
Blueprint Medicines Corporation and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Corcept Therapeutics Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Alpine Immune Sciences, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Bausch Health Companies Inc. vs ImmunityBio, Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Bausch Health Companies Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared